Targeted Cancer Treatments
• Biotech
Jobs from the company:
Page 1 / 1
IOmx Therapeutics AG
201-500
FTE
IOmx Therapeutics AG is dedicated to developing innovative, next-generation therapies aimed at harnessing the immune system to combat cancer. The company focuses on targeted immunotherapy treatments that enhance patient care and provide new hope for those affected by cancer.
Funding
€105M
HQ City
Planegg
Revenue Model
B2B
Employee Count
201-500
Last Funding Round
10/2021
Stage
Late
Team Growth
33%
YoY Website Traffic Growth
-21%
